These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 22461187)
21. Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work? Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M; Ann Rheum Dis; 2017 Jul; 76(7):1245-1252. PubMed ID: 28073801 [TBL] [Abstract][Full Text] [Related]
22. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. van Gaalen FA; Linn-Rasker SP; van Venrooij WJ; de Jong BA; Breedveld FC; Verweij CL; Toes RE; Huizinga TW Arthritis Rheum; 2004 Mar; 50(3):709-15. PubMed ID: 15022309 [TBL] [Abstract][Full Text] [Related]
23. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort. Olofsson T; Petersson IF; Eriksson JK; Englund M; Simard JF; Nilsson JÅ; Geborek P; Jacobsson LT; Askling J; Neovius M Ann Rheum Dis; 2014 May; 73(5):845-53. PubMed ID: 23520035 [TBL] [Abstract][Full Text] [Related]
24. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study. Verschueren P; Esselens G; Westhovens R Scand J Rheumatol; 2009; 38(3):166-72. PubMed ID: 19169906 [TBL] [Abstract][Full Text] [Related]
25. PREVALENCE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS CLASSIFIED AS RHEUMATOID AND UNDIFFERENTIATED ARTHRITIS AT KENYATTA NATIONAL HOSPITAL. Ayunga AO; Oyoo GO; Amayo EO; Angela AA East Afr Med J; 2012 Jun; 89(6):206-11. PubMed ID: 26856043 [TBL] [Abstract][Full Text] [Related]
26. Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina. Citera G; Ficco HM; Alamino RS; Pra FD; Lencina V; Casalla L; Benegas M; Rillo O; Berman A; Barbaglia AL; Bellomío V; Salinas MH; Alvarez AC; Caeiro F; Marcos J; Salas A; Pellet AC; Techera L; Secco A; Paira S; Ceccato F; Bedrán Z; Soriano ER; Marin J; Salvatierra G; Crespo ME Clin Rheumatol; 2015 May; 34(5):929-33. PubMed ID: 25425494 [TBL] [Abstract][Full Text] [Related]
27. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Liao KP; Batra KL; Chibnik L; Schur PH; Costenbader KH Ann Rheum Dis; 2008 Nov; 67(11):1557-61. PubMed ID: 18234714 [TBL] [Abstract][Full Text] [Related]
28. Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register. Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM Arthritis Rheumatol; 2017 Aug; 69(8):1566-1575. PubMed ID: 28425173 [TBL] [Abstract][Full Text] [Related]
29. Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH study. Pyne L; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Keystone EC; Pope JE; J Rheumatol; 2012 Nov; 39(11):2081-7. PubMed ID: 22942265 [TBL] [Abstract][Full Text] [Related]
30. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis. Barra L; Pope JE; Orav JE; Boire G; Haraoui B; Hitchon C; Keystone EC; Thorne JC; Tin D; Bykerk VP; J Rheumatol; 2014 Dec; 41(12):2361-9. PubMed ID: 25274884 [TBL] [Abstract][Full Text] [Related]
31. Prevalence, Course, and Associated Factors of Pain in the Temporomandibular Joint in Early Rheumatoid Arthritis: Results of a Longitudinal Cohort Study. Chin Jen Sem JP; van der Leeden M; Visscher CM; Britsemmer K; Turk SA; Dekker J; van Schaardenburg D; Lobbezoo F J Oral Facial Pain Headache; 2017; 31(3):233-239. PubMed ID: 28738108 [TBL] [Abstract][Full Text] [Related]
32. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis. Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044 [TBL] [Abstract][Full Text] [Related]
33. Combining anti-cyclic citrullinated peptide with the American College of Rheumatology 1987 criteria failed to improve early rheumatoid arthritis diagnosis in the community-based very early arthritis cohort. Le Loët X; Strotz V; Lequerré T; Boumier P; Pouplin S; Mejjad O; Daragon A; Jouen F; Vittecoq O; Fardellone P; Ménard JF Rheumatology (Oxford); 2011 Oct; 50(10):1901-7. PubMed ID: 21750000 [TBL] [Abstract][Full Text] [Related]
34. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Quinn MA; Gough AK; Green MJ; Devlin J; Hensor EM; Greenstein A; Fraser A; Emery P Rheumatology (Oxford); 2006 Apr; 45(4):478-80. PubMed ID: 16287917 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort. Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234 [TBL] [Abstract][Full Text] [Related]
36. Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study. Emamifar A; Hangaard J; Jensen Hansen IM Medicine (Baltimore); 2017 Oct; 96(43):e8357. PubMed ID: 29069018 [TBL] [Abstract][Full Text] [Related]
37. Work ability in rheumatoid arthritis patients: a register study on the prospective risk of exclusion and probability of returning to work. Hansen SM; Hetland ML; Pedersen J; Østergaard M; Rubak TS; Bjorner JB Rheumatology (Oxford); 2017 Jul; 56(7):1135-1143. PubMed ID: 28371921 [TBL] [Abstract][Full Text] [Related]
38. The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis. Cader MZ; Filer AD; Buckley CD; Raza K BMC Musculoskelet Disord; 2010 Aug; 11():187. PubMed ID: 20731815 [TBL] [Abstract][Full Text] [Related]
39. Work disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort. McWilliams DF; Varughese S; Young A; Kiely PD; Walsh DA Rheumatology (Oxford); 2014 Mar; 53(3):473-81. PubMed ID: 24241033 [TBL] [Abstract][Full Text] [Related]
40. Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis. Burr ML; Viatte S; Bukhari M; Plant D; Symmons DP; Thomson W; Barton A Arthritis Res Ther; 2012 May; 14(3):R109. PubMed ID: 22571727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]